Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera - PubMed (original) (raw)

Comparative Study

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera

R L Ashley et al. J Clin Microbiol. 1988 Apr.

Abstract

Sera from patients with culture-proven genital herpes infections were tested for herpes simplex virus type 1 (HSV-1)- and HSV-2-specific antibodies by both a Western blot (immunoblot) technique (WBA) and immunodot enzyme assays (IEAs) specific for HSV-1 or HSV-2 glycoprotein G (gG). Of 137 serum samples tested, none was mistyped by either WBA or IEA. Both tests were most sensitive with sera obtained at least 21 days after onset of primary HSV-2 infections or sera drawn during recurrent HSV-2 genital episodes: 75 of 76 (99%) such serum samples were positive for HSV-2 antibody by WBA and 73 of 76 (96%) were positive by IEA. Of sera drawn earlier than 21 days from onset of primary genital HSV-2, antibodies to HSV-2 were detected in 25% by WBA and 8% by IEA. In patients with culture-proven primary genital HSV-1 infection, WBA detected antibodies to HSV-1 proteins in 16 of 17 (94%) serum samples drawn at least 21 days after onset of primary genital HSV-1 infection, compared with 9 of 17 (53%) serum samples tested for gG-1 by IEA. Both WBA and IEA are accurate and sensitive tests for HSV-2 antibody in patients convalescing from a first episode or having symptomatic or asymptomatic recurrent genital herpes. WBA was more sensitive than IEA in detecting seroconversion following primary HSV-1 genital herpes, although both assays may miss persons undergoing early seroconversion to HSV-2.

PubMed Disclaimer

Cited by

Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.
Hosken N, McGowan P, Meier A, Koelle DM, Sleath P, Wagener F, Elliott M, Grabstein K, Posavad C, Corey L. Hosken N, et al. J Virol. 2006 Jun;80(11):5509-15. doi: 10.1128/JVI.02659-05. J Virol. 2006. PMID: 16699031 Free PMC article.
Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus.
Koelle DM, Liu Z, McClurkan CM, Topp MS, Riddell SR, Pamer EG, Johnson AS, Wald A, Corey L. Koelle DM, et al. J Clin Invest. 2002 Aug;110(4):537-48. doi: 10.1172/JCI15537. J Clin Invest. 2002. PMID: 12189248 Free PMC article.
Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment.
Melville J, Sniffen S, Crosby R, Salazar L, Whittington W, Dithmer-Schreck D, DiClemente R, Wald A. Melville J, et al. Sex Transm Infect. 2003 Aug;79(4):280-5. doi: 10.1136/sti.79.4.280. Sex Transm Infect. 2003. PMID: 12902574 Free PMC article.
Comparison of herpes simplex virus 1 genomic diversity between adult sexual transmission partners with genital infection.
Rathbun MM, Shipley MM, Bowen CD, Selke S, Wald A, Johnston C, Szpara ML. Rathbun MM, et al. PLoS Pathog. 2022 May 19;18(5):e1010437. doi: 10.1371/journal.ppat.1010437. eCollection 2022 May. PLoS Pathog. 2022. PMID: 35587470 Free PMC article.
Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection.
Tronstein E, Johnston C, Huang ML, Selke S, Magaret A, Warren T, Corey L, Wald A. Tronstein E, et al. JAMA. 2011 Apr 13;305(14):1441-9. doi: 10.1001/jama.2011.420. JAMA. 2011. PMID: 21486977 Free PMC article.

References

1. Am J Epidemiol. 1970 Jun;91(6):539-46 - PubMed
1. J Virol Methods. 1987 Nov;18(2-3):159-68 - PubMed
1. Cancer Res. 1973 Jun;33(6):1469-76 - PubMed
1. Am J Epidemiol. 1976 Aug;104(2):192-201 - PubMed
1. N Engl J Med. 1982 Jun 3;306(22):1313-9 - PubMed

Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera - PubMed (original) (raw)